In renal cancer, glutamine depletion leads to activation of HIF-1α and promotes secretion of IL-23 by tumor-infiltrating macrophages to activate regulatory T cell proliferation and enhance expression of IL-10 and transforming growth factor β, thereby inhibiting tumor cell killing by cytotoxic lymphocytes [116]. The gene discussed is HIF1A; the disease is neoplasm.